Publication: Epi-miRNAs: regulators of the histone modification machinery in human cancer
dc.contributor.coauthor | Sohrabi, B. | |
dc.contributor.coauthor | Mosallaei, M. | |
dc.contributor.coauthor | Nariman Saleh Fam, Z. | |
dc.contributor.coauthor | Bastami, M. | |
dc.contributor.coauthor | Mansoori, Y. | |
dc.contributor.coauthor | Daraei, A. | |
dc.contributor.coauthor | Zununi Vahed, S. | |
dc.contributor.coauthor | Navid, S. | |
dc.contributor.coauthor | Saadatian, Z. | |
dc.contributor.coauthor | Jamialahmadi, T. | |
dc.contributor.coauthor | Teng, Y. | |
dc.contributor.coauthor | Sahebkar A. | |
dc.contributor.department | KUTTAM (Koç University Research Center for Translational Medicine) | |
dc.contributor.kuauthor | Mortazavi, Deniz | |
dc.contributor.schoolcollegeinstitute | Research Center | |
dc.date.accessioned | 2024-11-09T12:18:15Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Cancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes after transcription. Various microRNAs control the expression of histone modifiers and are involved in a variety of cancers. Therefore, overexpression or downregulation of microRNAs can alter cell fate and cause malignancies. In this review, we discuss the role of microRNAs in regulating the histone modification machinery in various cancers, with a focus on the histone-modifying enzymes such as acetylases, deacetylases, methyltransferases, demethylases, kinases, phosphatases, desumoylases, ubiquitinases, and deubiquitinases. Understanding of microRNA-related aberrations underlying histone modifiers in pathogenesis of different cancers can help identify novel therapeutic targets or early detection approaches that allow better management of patients or monitoring of treatment response. | |
dc.description.fulltext | YES | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | N/A | |
dc.description.version | Publisher version | |
dc.description.volume | 2022 | |
dc.identifier.doi | 10.1155/2022/4889807 | |
dc.identifier.eissn | 1687-8469 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR03443 | |
dc.identifier.issn | 1687-8450 | |
dc.identifier.quartile | Q2 | |
dc.identifier.scopus | 2-s2.0-85124007181 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/1452 | |
dc.identifier.wos | 769753800001 | |
dc.keywords | Transcription factor EZH2 | |
dc.keywords | Polycomb repressive complex 2 | |
dc.keywords | Epigenetics | |
dc.language.iso | eng | |
dc.publisher | Hindawi | |
dc.relation.grantno | NA | |
dc.relation.ispartof | Journal of Oncology | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10237 | |
dc.subject | Oncology | |
dc.title | Epi-miRNAs: regulators of the histone modification machinery in human cancer | |
dc.type | Review | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Mortazavi, Deniz | |
local.publication.orgunit1 | Research Center | |
local.publication.orgunit2 | KUTTAM (Koç University Research Center for Translational Medicine) | |
relation.isOrgUnitOfPublication | 91bbe15d-017f-446b-b102-ce755523d939 | |
relation.isOrgUnitOfPublication.latestForDiscovery | 91bbe15d-017f-446b-b102-ce755523d939 | |
relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | d437580f-9309-4ecb-864a-4af58309d287 |
Files
Original bundle
1 - 1 of 1